LFCR Stock Price
Lifecore Biomedical, Inc.
LFCR stock price is $6.44 (-0.08% on the day), giving Lifecore Biomedical, Inc. a market cap of $243.77M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
LFCR Stock Overview
- Price
- $6.43
- Previous close
- $6.44
- Open
- $6.43
- Market cap
- $243.77M
- 52-week range
- $3.63 - $8.98
- 1-year price target
- $5.64
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Exchange
- NGS
- MarketXLS Rank
- 73
About Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LFCR | $6.44 | -0.1% | 259.19K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Lifecore Biomedical, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW